Lista de obras - Phil F Cheng - Dominio Público Uruguay

A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma

artículo científico publicado en 2018

A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma

scientific article published on 10 October 2019

Activation of CD8+ T cells contributes to anti-tumor effects of CDK4/6 inhibitors plus MEK inhibitors

artículo científico publicado en 2020

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.

artículo científico publicado en 2016

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

artículo científico publicado en 2015

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

artículo científico publicado en 2015

Basal cell carcinomas in a tertiary referral centre: a systematic analysis.

artículo científico publicado en 2014

CARD14 gain-of-function mutation alone is sufficient to drive IL-23/IL-17-mediated psoriasiform skin inflammation in vivo.

artículo científico publicado en 2018

Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.

artículo científico publicado en 2016

Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients.

artículo científico publicado en 2014

Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

scientific article published on 01 December 2018

Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5

artículo científico publicado en 2022

Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

artículo científico publicado en 2016

Data mining The Cancer Genome Atlas in the era of precision cancer medicine

artículo científico publicado en 2015

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma.

artículo científico publicado en 2015

Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?

artículo científico publicado en 2017

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation

scientific article published on 28 June 2018

Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4

artículo científico publicado en 2021

Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma

artículo científico publicado en 2017

Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma.

artículo científico publicado en 2015

Histological evaluation of a "residual" metastasis after ipilimumab therapy in a patient with advanced melanoma

artículo científico publicado en 2015

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

artículo científico publicado en 2018

In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma

artículo científico publicado en 2015

Increased tumour cell PD-L1-expression, macrophage and dendritic cell infiltration characterise the tumour microenvironment of ulcerated primary melanomas

artículo científico publicado en 2018

Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2.

artículo científico publicado en 2015

Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.

artículo científico publicado en 2017

Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma

artículo científico publicado en 2019

Lipoconstruct surface topography grating size influences vascularization onset in the dorsal skinfold chamber model

scientific article published on 08 February 2020

Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation

artículo científico publicado en 2015

Medical bioinformatics in melanoma

artículo científico publicado en 2017

Melanoma Immunotherapy: Next-Generation Biomarkers.

artículo científico publicado en 2018

Melanoma patients with additional primary cancers: a single-center retrospective analysis.

artículo científico publicado en 2019

Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis

artículo científico publicado en 2018

Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages.

artículo científico publicado en 2014

Metastatic melanoma moves on: translational science in the era of personalized medicine.

artículo científico publicado en 2017

Methadone-Not a magic bullet in melanoma therapy

scientific article published on 01 June 2018

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma

artículo científico publicado en 2015

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

artículo científico publicado en 2017

Osmoregulatory function of large vacuoles found in notochordal cells of the intervertebral disc running title: an osmoregulatory vacuole.

artículo científico publicado en 2007

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.

artículo científico publicado en 2016

Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma

artículo científico publicado en 2018

Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential

artículo científico publicado en 2019

Proteomic identification of a marker signature for MAPKi resistance in melanoma

scientific article published on 26 June 2019

Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma.

artículo científico publicado en 2016

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.

artículo científico publicado en 2018

Publisher Correction: The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma

artículo científico publicado en 2018

Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation

artículo científico publicado en 2018

Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.

artículo científico publicado en 2015

SMAD signaling promotes melanoma metastasis independently of phenotype switching

artículo científico publicado en 2019

Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer

artículo científico publicado en 2017

Sox2 is dispensable for primary melanoma and metastasis formation

artículo científico publicado en 2017

Systematic classification of melanoma cells by phenotype-specific gene expression mapping.

artículo científico publicado en 2012

The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress

scientific article published on 09 October 2020

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

artículo científico publicado en 2020

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

artículo científico publicado en 2015

The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma

artículo científico publicado en 2018

Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy.

artículo científico publicado en 2015

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.

artículo científico publicado en 2018

low neurotrophin receptor CD271 regulates phenotype switching in melanoma

artículo científico publicado en 2017

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

artículo científico publicado en 2016

Lista de obras de Phil F Cheng

A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma

A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma

Activation of CD8+ T cells contributes to anti-tumor effects of CDK4/6 inhibitors plus MEK inhibitors

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

Basal cell carcinomas in a tertiary referral centre: a systematic analysis.

CARD14 gain-of-function mutation alone is sufficient to drive IL-23/IL-17-mediated psoriasiform skin inflammation in vivo.

Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.

Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients.

Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5

Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

Data mining The Cancer Genome Atlas in the era of precision cancer medicine

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma.

Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation

Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4

Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma

Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma.

Histological evaluation of a "residual" metastasis after ipilimumab therapy in a patient with advanced melanoma

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma

Increased tumour cell PD-L1-expression, macrophage and dendritic cell infiltration characterise the tumour microenvironment of ulcerated primary melanomas

Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2.

Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.

Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma

Lipoconstruct surface topography grating size influences vascularization onset in the dorsal skinfold chamber model

Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation

Medical bioinformatics in melanoma

Melanoma Immunotherapy: Next-Generation Biomarkers.

Melanoma patients with additional primary cancers: a single-center retrospective analysis.

Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis

Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages.

Metastatic melanoma moves on: translational science in the era of personalized medicine.

Methadone-Not a magic bullet in melanoma therapy

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Osmoregulatory function of large vacuoles found in notochordal cells of the intervertebral disc running title: an osmoregulatory vacuole.

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.

Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma

Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential

Proteomic identification of a marker signature for MAPKi resistance in melanoma

Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma.

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.

Publisher Correction: The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma

Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation

Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.

SMAD signaling promotes melanoma metastasis independently of phenotype switching

Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer

Sox2 is dispensable for primary melanoma and metastasis formation

Systematic classification of melanoma cells by phenotype-specific gene expression mapping.

The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma

Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy.

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.

low neurotrophin receptor CD271 regulates phenotype switching in melanoma

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance